Cargando…
DNA Damage Repair Gene Set as a Potential Biomarker for Stratifying Patients with High Tumor Mutational Burden
SIMPLE SUMMARY: Immunotherapy has been a promising therapeutic approach for cancer treatment in recent years. Although cancer immunotherapy has achieved remarkable success, treatment response is only observed in a small number of patients. As nonresponders need to endure high treatment costs and tox...
Autores principales: | Chiu, To-Yuan, Lin, Ryan Weihsiang, Huang, Chien-Jung, Yeh, Da-Wei, Wang, Yu-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231881/ https://www.ncbi.nlm.nih.gov/pubmed/34198473 http://dx.doi.org/10.3390/biology10060528 |
Ejemplares similares
-
High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
por: Mei, Ping, et al.
Publicado: (2020) -
Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
por: Teng, Xu, et al.
Publicado: (2023) -
Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung Adenocarcinoma
por: Wu, Dongping, et al.
Publicado: (2022) -
DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients
por: Gu, Weiguang, et al.
Publicado: (2023) -
DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
por: Dai, Jiawei, et al.
Publicado: (2021)